Schlusskurs
Andere Börsenplätze
|
||
- GBX | - |
|
05.07. | Jefferies stuft Softcat auf 'underperform' zurück | AN |
04.07. | Victrex sieht einige grüne Triebe, aber der Handel im Chemiebereich ist eine Herausforderung | AN |
Kurzporträt
Umsatz nach Geschäftsbereich
GBP in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Sustainable Solutions
78,8
%
| 283 | 82,9 % | 242 | 78,8 % | -14.47% |
Medical
21,2
%
| 58 | 17,1 % | 65 | 21,2 % | +11.84% |
Umsatz je Region
GBP in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
24,7
%
| 88 | 25,7 % | 76 | 24,7 % | -13.58% |
Germany
23,8
%
| 90 | 26,4 % | 73 | 23,8 % | -18.76% |
Europe, the Middle East and Africa ('EMEA')
17,7
%
| 54 | 15,9 % | 54 | 17,7 % | +0.37% |
Asia-Pacific
15,3
%
| 58 | 16,9 % | 47 | 15,3 % | -18.40% |
China
14,8
%
| 40 | 11,8 % | 46 | 14,8 % | +12.90% |
Americas
2,3
%
| 7 | 2,0 % | 7 | 2,3 % | +1.45% |
United Kingdom
1,4
%
| 4 | 1,3 % | 4 | 1,4 % | -2.33% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Jakob Sigurðsson
CEO | Chief Executive Officer | 60 | 01.09.17 |
Michael Ward
DFI | Director of Finance/CFO | - | - |
Ian Melling
DFI | Director of Finance/CFO | - | 04.07.22 |
Andrew Hanson
IRC | Investor Relations Contact | - | - |
Jane Brisley
LAW | General Counsel | - | 01.07.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Jakob Sigurðsson
CEO | Chief Executive Officer | 60 | 01.09.17 |
Dame Cox
CHM | Chairman | 64 | 01.12.21 |
Brendan Connolly
BRD | Director/Board Member | 68 | 09.02.18 |
David Thomas
BRD | Director/Board Member | 69 | 14.05.18 |
Janet Ashdown
BRD | Director/Board Member | 65 | 09.02.18 |
Rosalind Rivaz
BRD | Director/Board Member | 68 | 01.05.20 |
Jane Toogood
BRD | Director/Board Member | - | 01.09.15 |
Ian Melling
DFI | Director of Finance/CFO | - | 04.07.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 87 034 903 | 85 612 639 ( 98,37 %) | 0 | 98,37 % |
Unternehmenskontakt
Victrex Plc
Victrex Technology Centre Hillhouse International
FY5 4QD, Thornton Cleveleys
+44 12 5389 7700
http://www.victrex.com![Straße Victrex plc(VCT)](https://cdn.zonebourse.com/static/address/9676691.png)
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Invibio Ltd.
![]() Invibio Ltd. Pharmaceuticals: MajorHealth Technology Part of Victrex Plc, Invibio Ltd. is a British company founded in 1999 that specializes in producing peek-optima™ polymers for use in a variety of medical implants. The company is based in Cleveleys, UK and their products are widely used by surgical healthcare professionals. For more information on their products, visit their website. |
Pharmaceuticals: Major
|
Victrex Manufacturing Ltd.
![]() Victrex Manufacturing Ltd. Miscellaneous ManufacturingProducer Manufacturing Part of Victrex Plc, Victrex Manufacturing Ltd. is a British company that manufactures plastic products. The company is based in Thornton-Cleveleys, UK. Founded in 1993. |
Miscellaneous Manufacturing
|
Umsatz nach Geschäftsbereich
Umsatz je Region
% 1. Jan. | Kap. | |
---|---|---|
+23.61% | 69.07 Mrd. | |
-3.98% | 46.81 Mrd. | |
+23.25% | 44.24 Mrd. | |
+35.57% | 29.06 Mrd. | |
+6.31% | 18.51 Mrd. | |
+13.16% | 17.34 Mrd. | |
-5.06% | 15.6 Mrd. | |
-28.83% | 15.04 Mrd. | |
-29.23% | 11.91 Mrd. |
- Börse
- Aktien
- 898554 Aktie
- VCT Aktie
- Unternehmen Victrex plc